Compositions and methods for the diagnosis and treatment of tumor

Details for Australian Patent Application No. 2002367318 (hide)

Owner Genentech, Inc.

Inventors Williams, P Mickey; Hillan, Kenneth J; Smith, Victoria; Zhang, Zemin; Frantz, Gretchen; Spencer, Susan D; Wu, Thomas D; Phillips, Heidi; Polakis, Paul

Agent Griffith Hack

Pub. Number AU-B-2002367318

PCT Number PCT/US02/41798

PCT Pub. Number WO2003/057160

Priority 60/405,645 21.08.02 US; 60/366,284 21.03.02 US; 60/351,885 25.01.02 US; 60/360,066 25.02.02 US; 60/368,679 28.03.02 US; 60/366,869 20.03.02 US; 60/345,444 02.01.02 US; 60/362,004 05.03.02 US; 60/404,809 19.08.02 US

Filing date 30 December 2002

Wipo publication date 24 July 2003

Acceptance publication date 12 July 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2002367318

4 September 2003 Complete Application Filed

  Priority application(s): 60/405,645 21.08.02 US; 60/366,284 21.03.02 US; 60/351,885 25.01.02 US; 60/360,066 25.02.02 US; 60/368,679 28.03.02 US; 60/366,869 20.03.02 US; 60/345,444 02.01.02 US; 60/362,004 05.03.02 US; 60/404,809 19.08.02 US

12 July 2007 Application Accepted

  Published as AU-B-2002367318

15 November 2007 Standard Patent Sealed

28 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002367319-System for monitoring bacterial tumor treatment

2002367317-PSORIASIN EXPRESSION BY BREAST EPITHELIAL CELLS